Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T3-4-Hypo: LT4/LT3 Combination Therapy in Autoimmune Hypothyroidism
NCT05682482Phase 3Recruiting
- Start
- Oct 2022
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of liothyronine in Hashimoto's thyroiditis (HT). Started Oct 2022; status: recruiting.
02
Drugs
liothyronine
03
Conditions
Hashimoto's thyroiditis (HT)
Beyond the preview
Go deeper on NCT05682482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05682482.